WALTHAM, Mass., April 23, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (APLS), a global biopharmaceutical company and leader in complement, today announced post hoc analyses from the ...
Two commonly delivered epidural injection modalities deliver minimal differences in pain relief and function at 1 and 6 months, new research shows. Results presented today at the 30th Annual Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback